Clinical Trial Update: A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956) [Phase 2]

View source ↗

Summary

A Phase 2 bridging trial comparing Sugammadex (Org 25969) at reappearance of T2 in Japanese vs Caucasian participants (Part A: Japanese Participants).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia General

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 2 | Status: COMPLETED | Results posted: 2019-02-08